522 related articles for article (PubMed ID: 9157992)
1. Mutational activation of pp60(c-src) leads to a tumorigenic phenotype in a preneoplastic Syrian hamster embryo cell line.
Lansing TJ; Turk BF; Kanner SB; Gilmer TM
Cancer Res; 1997 May; 57(10):1962-9. PubMed ID: 9157992
[TBL] [Abstract][Full Text] [Related]
2. Activation of pp60c-src tyrosine kinase specific activity in tumor-derived Syrian hamster embryo cells.
Kanner SB; Parsons SJ; Parsons JT; Gilmer TM
Oncogene; 1988 Apr; 2(4):327-35. PubMed ID: 2452399
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
Cobb BS; Parsons JT
Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
[TBL] [Abstract][Full Text] [Related]
4. Correlation of V-src gene amplification with the tumorigenic phenotype in a Syrian hamster embryo cell line.
Gilmer TM; Lamb PW; Oshimura M; Barrett JC
Cancer Res; 1987 Sep; 47(17):4663-6. PubMed ID: 3040229
[TBL] [Abstract][Full Text] [Related]
5. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
Potts WM; Reynolds AB; Lansing TJ; Parsons JT
Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
[TBL] [Abstract][Full Text] [Related]
6. Novel tyrosine phosphorylations accompany the activation of pp60c-src during chemical carcinogenesis.
Kanner SB; Gilmer TM; Reynolds AB; Parsons JT
Oncogene; 1989 Mar; 4(3):295-300. PubMed ID: 2468123
[TBL] [Abstract][Full Text] [Related]
7. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
Tian M; Martin GS
Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of Src mutants at Tyr 527 in fibroblasts does not correlate with in vitro phosphorylation by CSK.
MacAuley A; Okada M; Nada S; Nakagawa H; Cooper JA
Oncogene; 1993 Jan; 8(1):117-24. PubMed ID: 7678701
[TBL] [Abstract][Full Text] [Related]
9. Altered tyrosine 527 phosphorylation and mitotic activation of p60c-src.
Bagrodia S; Chackalaparampil I; Kmiecik TE; Shalloway D
Nature; 1991 Jan; 349(6305):172-5. PubMed ID: 1702522
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine phosphorylation of caveolin-2 at residue 27: differences in the spatial and temporal behavior of phospho-Cav-2 (pY19 and pY27).
Wang XB; Lee H; Capozza F; Marmon S; Sotgia F; Brooks JW; Campos-Gonzalez R; Lisanti MP
Biochemistry; 2004 Nov; 43(43):13694-706. PubMed ID: 15504032
[TBL] [Abstract][Full Text] [Related]
11. Evidence for multiple steps in neoplastic transformation of normal and preneoplastic Syrian hamster embryo cells following transfection with Harvey murine sarcoma virus oncogene (v-Ha-ras).
Thomassen DG; Gilmer TM; Annab LA; Barrett JC
Cancer Res; 1985 Feb; 45(2):726-32. PubMed ID: 2981612
[TBL] [Abstract][Full Text] [Related]
12. Characterization of avian retroviruses carrying activated transforming human c-src genes and of steps involved in expression of activated src-PKases in vitro.
Tanaka A; Salem M; Eckroade RJ; Fujita DJ
Oncogene Res; 1990; 5(4):305-22. PubMed ID: 2168536
[TBL] [Abstract][Full Text] [Related]
13. Cloning and characterization of a thermolabile v-src gene for use in reversible transformation of mammalian cells.
Maroney AC; Qureshi SA; Foster DA; Brugge JS
Oncogene; 1992 Jun; 7(6):1207-14. PubMed ID: 1375718
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of NOS3 in a breast cancer cell line and Src-transformed cells.
Takenouchi Y; Oo ML; Senga T; Watanabe Y; Machida K; Miyazaki K; Nimura Y; Hamaguchi M
Oncol Rep; 2004 May; 11(5):1059-62. PubMed ID: 15069547
[TBL] [Abstract][Full Text] [Related]
15. Transformation of mouse cells by wild-type mouse c-Src.
Lin PH; Shenoy S; Galitski T; Shalloway D
Oncogene; 1995 Jan; 10(2):401-5. PubMed ID: 7530829
[TBL] [Abstract][Full Text] [Related]
16. pp60c-Src phosphorylates and activates vacuolar protein sorting 34 to mediate cellular transformation.
Hirsch DS; Shen Y; Dokmanovic M; Wu WJ
Cancer Res; 2010 Jul; 70(14):5974-83. PubMed ID: 20551057
[TBL] [Abstract][Full Text] [Related]
17. Activating SRC mutation in a subset of advanced human colon cancers.
Irby RB; Mao W; Coppola D; Kang J; Loubeau JM; Trudeau W; Karl R; Fujita DJ; Jove R; Yeatman TJ
Nat Genet; 1999 Feb; 21(2):187-90. PubMed ID: 9988270
[TBL] [Abstract][Full Text] [Related]
18. Generation and characterization of transforming variants of the lck tyrosine protein kinase.
Adler HT; Sefton BM
Oncogene; 1992 Jun; 7(6):1191-9. PubMed ID: 1594248
[TBL] [Abstract][Full Text] [Related]
19. Two novel variants of the v-src oncogene isolated from low and high metastatic RSV-transformed hamster cells.
Tatosyan A; Yatsula B; Shtutman M; Moinova E; Kaverina I; Musatkina E; Leskov K; Mizenina O; Zueva E; Calothy G; Dezélée P
Virology; 1996 Feb; 216(2):347-56. PubMed ID: 8607264
[TBL] [Abstract][Full Text] [Related]
20. Frequent activation of non-ras transforming sequences in neoplastic Syrian hamster cells initiated with chemical carcinogens.
Notario V; Castro R; Flessate DM; Doniger J; DiPaolo JA
Oncogene; 1990 Sep; 5(9):1425-30. PubMed ID: 2216466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
